Error: Could not add to watchlist. X

Inhibitex LLC

+ Watchlist
INHX:US
Acquired
INHX:US was acquired by BMY:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.37
Market Cap (USD)
-
Shares Outstanding (m)
78.293
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Inhibitex, LLC. provides biopharmaceutical products. The Company discovers, develops, and commercializes novel antibody-based products for the prevention and treatment of serious bacterial and fungal infections in the hospital setting. Inhibitex serves customers throughout the United States.
ADDRESS
1165 Sanctuary Parkway
Suite 400
Alpharetta, GA 30004
United States
PHONE
1-678-746-1100
WEBSITE
-
  • Geoffrey W Henson
    Senior VP:Drug Development
Show More